No proposal to change Covishield, Covaxin, and Sputnik V dose Interval: NTAGI Chief Dr Nk Arora

·1-min read
NTAGI chairman Dr Nk Arora. (Photo/ANI)
NTAGI chairman Dr Nk Arora. (Photo/ANI)

By Shalini Bhardwaj

New Delhi [India], August 26 (ANI): There is no proposal in consideration to change the dose interval between two COVID-19 vaccines--Covishield, Covaxin, and Sputnik V in India, National Technical Advisory Group on Immunisation's (NTAGI) chairman Dr Nk Arora said on Thursday.

Arora while speaking to ANI said, "There are several studies and programmatic data collection processes are on to assess the vaccine effectiveness. NTAGI is reviewing the vaccine effectiveness data on regular basis. Currently, there is no proposal for change in the interval of doses for COVISHIELD, COVAXIN, and SPUTNIK V under consideration."

Earlier there were reports that government could make a move to reduce the minimum gap between two doses of the Covishield COVID-19 vaccine, but NTAGI has denied the reports.

At present, Covishield is being administered in the country with the two doses having a gap of 12-16 weeks.

In the month of MAY this year, the gap was increased from 6-8 weeks to 12-16 weeks.

When the nationwide vaccination has started in January this year, the Covishield dosage gap was set at 4-6 weeks. (ANI)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting